William R. Patterson, Ph.D.

VP, R&D and Operations

Bill joined Sequent in May 2010. He has 16 years of medical device experience and 5 years of academic biophysics experience. Bill holds BS and PhD degrees from UC Davis and UC Irvine, respectively, and did a postdoctoral fellowship at UCLA. Before and after his PhD, Bill worked in R&D positions of increasing responsibility for Baxter Healthcare, TherOx, Micro Therapeutics, ev3, and Luminous Medical. He has a proven track record of converting ideas into commercial medical devices, particularly in the neurovascular space. With over 30 issued and pending US patents, Bill participated in the successful PMA approval for Onyx and developed the Micro Therapeutics/ev3 aneurysm products Nexus, Morpheus, and Axium.